Skip to content

Author

C. Yılmaz

We have 2 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Treatment Sequencing of CDK4/6 Inhibitors in Bone-Only Hormone Receptor-Positive Metastatic Breast Cancer: Multi-Center Real-World Data Revealing a Numerical Trend Favoring Later-Line Use

Real-world findings highlight the need for personalized treatment sequencing in HR+/HER2− MBC patients presenting with bone-only metastasis, and first-line use showed a trend toward longer PFS, while later-line use showed a numerical trend toward longer OS.

S. Yıldırım, Büşra Bülbül, Bekir Ucun et al. · 0 citations
Open access Aug 2026

Association of Pre-Diagnosis Breast Assessment Practices and Risk Factors with Breast Cancer Stage at Diagnosis: A Single-Center Cross-Sectional Study

Self-reported biennial mammography was associated with earlier stage and lower odds of metastatic disease at diagnosis and smoking and hormonal medication use showed inverse associations, but these findings may reflect confounding or selection and should not be viewed as protective.

H. S. Küçükerdem, C. Yılmaz, Özden Gökdemir · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.